Alkaloid AD Skopje operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alkaloid AD Skopje with three other
pharmaceutical manufacturers in Europe:
sales of 1.10 billion Turkish Liras [US$181.04 million]
Deva Holding AS
(1.04 billion Turkish Liras [US$171.10 million]
of which 92%
was Pharmaceuticals), and
Karo Pharma AB
based in Sweden
(1.62 billion Swedish Kronor [US$165.03 million]
of which 100%
was Drugs Discovery & Dev).
Alkaloid AD Skopje reported sales of 9.78 billion Denar (US$171.40 million)
December of 2018.
increase of 7.6%
versus 2017, when the company's sales were 9.09 billion Denar.
Sales at Alkaloid AD Skopje have increased during each of the previous five years
(and since 2013, sales have increased a total of 38%).
Sales of Pharmaceuticals saw an increase
8.6% in 2018, from
7.70 billion Denar to 8.36 billion Denar.
Not all segments of Alkaloid AD Skopje experienced an increase in sales in 2018:
sales of Chemicals fell 18.5% to 234.04 million Denar.
(However, this segment's sales were only a very small portion of the company's overall sales).